Concepedia

Matthew C. Troutman

MC

4

Publications

190

Citations

4

H-Index

2015

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Rutgers, The State University of New Jersey

United States Military Academy

Rutgers New Jersey Medical School

Brown Foundation

Matthew C. Troutman is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in antibody engineering, immunology, and immunotherapy.

Top concepts

Publications per year

2015–2020

4

Publications

4

Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex

Sha Ha, Fengsheng Li, Matthew C. Troutman et al. · Journal of Virology · 2017 · 86 citations · Full text

Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination

Fengsheng Li, Daniel C. Freed, Aimin Tang et al. · npj Vaccines · 2017 · 49 citations · Full text

, , +16

Soluble Human Cytomegalovirus gH/gL/pUL128–131 Pentameric Complex, but Not gH/gL, Inhibits Viral Entry to Epithelial Cells and Presents Dominant Native Neutralizing Epitopes

John W. Loughney, Richard R. Rustandi, Dai Wang et al. · Journal of Biological Chemistry · 2015 · 44 citations · Full text

Monoclonal Antibody Reagent Stability and Expiry Recommendation Combining Experimental Data with Mathematical Modeling

Malorie Fink, Erin Marie Cannon, Carl Hofmann et al. · The AAPS Journal · 2020 · 11 citations

, , +8

Rows per page

1–4 of 4